G uanine nucleotide-binding proteins, or G-proteins, typically provide the major signal transducing step between agonist occupancy of a 7-transmembrane receptor and effector mechanisms. G-proteins consist of 3 subunits (a, b, and g); the b and g subunits are tightly bound and typically function as a "bg" subunit. Both the a and bg subunits serve signal transduction functions.
lyzes guanosine diphosphate (GDP)-guanosine triphosphate (GTP) exchange that results in temporary dissociation of a and bg subunits, and each is then free to effect downstream signaling via proteinprotein interactions. Signal transduction via free/activated a subunits is well known (e.g., stimulation and inhibition of adenylyl cyclase). bgÀsubunit-mediated signal transduction was appreciated later but is also important and includes muscarinic activation of cardiac Kir3.1 channels (1), b-adrenergic activation of G-protein-coupled receptor kinase-2 (GRK2) (2) , and GPCR responses known to be operative in vascular smooth muscle (3) (4) (5) .
In humans there are 16 (6), 5 (7), and 12 (7) different genes coding a, b, and g proteins, respectively. Mammalian b1 to b4 subunits have high amino acid homology and likely arose from a common ancestor, whereas b5 is less similar (w50% homology to b1 to b4) (7) . The large number of potential bg-subunit From the Division of Cardiology and Cardiovascular Institute, University of Colorado, Aurora, Colorado. Dr. Bristow has reported that he has no relationships relevant to the contents of this paper to disclose. Based on previous work by other laboratories, a possible explanation offered for these findings is an amplified effect of nitric oxide (NO) donation in GNB3
825T homozygotes (12,13) that countered enhanced vasoconstriction delivered by a 2 -adrenergic receptormediated vasoconstriction (13, 14) . This explanation, as well as the primary GNB3 polymorphism findings, should be considered hypothesis generating, but these findings are certainly worthy of further study.
The A-HeFT DNA substudy has also provided evidence that an NO synthase (NOS3) (15) and an aldosterone synthase (16) polymorphism are each associated with an enhanced BiDil treatment effect; because of the relatively small sample size, a possible interaction with these variants and GNB3 was not investigated (10) . For all 3 polymorphisms, the higher response variant is enriched in African Americans or in other populations of African descent (10, (15) (16) (17) (18) (19) .
Therefore, it is possible that multiple racially distributed genetic variants contribute to the presumed higher efficacy of BiDil in populations of African ancestry (11, 20) . However, relative to Caucasians the racial enrichment of the higher response allele is far greater for GNB3, by 2.1-fold (10) bristow@ucdenver.edu.
